Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
India flag India · Delayed Price · Currency is INR
175.18
+2.98 (1.73%)
May 29, 2026, 3:29 PM IST

Nath Bio-Genes (India) Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
3,2722,4522,7723,3082,6844,055
Market Cap Growth
6.78%-11.54%-16.20%23.22%-33.79%-28.93%
Enterprise Value
3,8983,9934,0264,2833,8364,810
Last Close Price
172.20129.02144.18170.54136.92204.18
PE Ratio
8.215.897.188.357.67-
PS Ratio
0.740.550.760.990.891.46
PB Ratio
0.480.360.430.540.470.75
P/TBV Ratio
0.480.360.440.550.480.77
P/FCF Ratio
--28.696.927.57-
P/OCF Ratio
--15.774.437.0023.78
EV/Sales Ratio
0.880.901.101.291.271.73
EV/EBITDA Ratio
7.437.617.918.567.8512.78
EV/EBIT Ratio
8.048.248.549.168.3613.92
EV/FCF Ratio
-25.02-41.678.9610.81-
Debt / Equity Ratio
0.200.200.190.180.180.17
Debt / EBITDA Ratio
2.642.642.412.212.152.47
Debt / FCF Ratio
--12.682.312.97-
Net Debt / Equity Ratio
0.090.090.050.050.120.16
Net Debt / EBITDA Ratio
1.191.190.660.661.382.36
Net Debt / FCF Ratio
-4.01-4.013.480.691.89-22.44
Asset Turnover
0.420.420.380.400.390.36
Inventory Turnover
0.510.510.320.410.380.42
Quick Ratio
0.410.410.510.680.660.50
Current Ratio
1.971.971.892.182.402.41
Return on Equity (ROE)
6.29%6.29%6.16%6.70%6.28%-11.67%
Return on Assets (ROA)
2.85%2.85%3.09%3.49%3.74%2.83%
Return on Invested Capital (ROIC)
5.53%6.13%6.79%6.95%6.99%5.26%
Return on Capital Employed (ROCE)
6.90%6.90%7.10%7.60%8.00%6.30%
Earnings Yield
12.72%16.98%13.93%11.98%13.04%-16.62%
FCF Yield
-4.76%-6.35%3.49%14.46%13.22%-0.98%
Dividend Yield
1.16%1.55%1.39%1.17%1.46%0.98%
Payout Ratio
9.13%9.13%9.85%9.59%10.86%-
Buyback Yield / Dilution
-4.41%-4.41%----
Total Shareholder Return
-3.25%-2.86%1.39%1.17%1.46%0.98%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.